Differential analyses of SEPN1 expression in cancer samples and adjacent non-cancerous samples across different cancer types showed upregulation of SEPN1 in cancers such as GBM, LGG, ESCA, STES, and PAAD. Here, SELENON is linked to glioblastoma.